Reference intervals for thyroid markers in early pregnancy determined by 7 different analytical systems

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 74, Issue 2, 2014, Pages 95-101

  Springer, Drahomira ^a   Bartos, Vladimir ^b   Zima, Tomas ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

Author keywords

Immunoassay; Pregnancy; Reference interval; Thyroid stimulating hormone; Thyroxine

Indexed keywords

BIOLOGICAL MARKER; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE;

ADULT; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN EXPERIMENT; IMMUNOASSAY; NORMAL HUMAN; PREGNANT WOMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REFERENCE VALUE; THYROID FUNCTION TEST;

ADULT; AUTOANTIBODIES; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMMUNOASSAY; PREGNANCY; PREGNANCY TRIMESTER, FIRST; REFERENCE VALUES; THYROID FUNCTION TESTS; THYROID GLAND; THYROTROPIN; THYROXINE;

EID: 84896346959     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2013.860617     Document Type: Article

References (38)

1. Vaidya B, Hubalewska-Dydejczyk A, Laurberg P, Negro P, Vermiglio F, Poppe K. Treatment and screening of hypothy-roidism in pregnancy: results of a European survey. Eur J Endocrinol 2012; 166: 49-54.
2. Casey BM, Dashe JS, Wells CE, McIntire DD, Leveno KJ, Cunningham FG. Subclinical hyperthyroidism and pregnancy outcomes. Obstet Gynecol 2006; 107: 337-41.
3. Lazarus JH, Premawardhana LD. Screening for thyroid disease in pregnancy. J Clin Pat 2005; 58: 449-52. (Pubitemid 40646862)
4. Morreale de Escobar G, Obregon MJ, Escobar del Rey F. Role of thyroid hormone during early brain development. Eur J Endocrinol 2004; 151: 25-37.
5. Li Y, Shan Z, Teng W, Y u X, Li Y, Fan C, Teng X, Guo R, Wang H, Li J, Chen Y, Wang W, Chawinga M, Zhang L, Yang L, Zhao Y, Hua T. Abnormalities of maternal thyroid function during pregnancy affect neuropsychological development of their children at 25-30 months. Clin Endocrinol 2010; 72: 825-9.
6. Stuckey BG, Kent GH, Ward LC, Brown SJ, Walsh JP. Postpartum thyroid dysfunction and the long-term risk of hypothyroidism: results from a 12-year follow-up study of women with and without postpartum thyroid dysfunction. Clin Endocrinol (Oxf) 2010; 73: 389-95.
7. Abalovich M, Amino N, Barbour LA, Cobin RH, De Groot LJ, Glinoer D, Mandel SJ, Stagnaro-Green A. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2007; 92: S1-47.
8. Stagnaro-Green A, Abalovich M, Alexander E, Fereidoun A, Mestman J, Negro R, Nixon A, Pearce EN, Soldin OP, Sullivan S, Wiersinga W. Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum. Thyroid 2011; 21: 1-45.
9. Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. J Clin Endocrinol Metab 2010; 95: 1699-707.
10. Lazarus JH, Bestwick JP, Channon S, Paradice R, Maina A, Rees R, Chiusano E, John R, Guaraldo V, George LM, Perona M, Dall'Amico D, Parkes AB, Joomun M, Wald NJ. Antenatal thyroid screening and childhood cognitive function. N Engl J Med 2012; 366: 493-501.
11. Vaidya B, Anthony S, Bilous M, Shields B, Drury J, Hutchison S. Detection of thyroid dysfunction in early pregnancy: universal screening or targeted high risk case finding? J Clin Endocrinol Metab 2007; 92: 203-7. (Pubitemid 46067531)
12. Springer D, Zima T, Limanova Z. Reference intervals in evaluation of maternal thyroid function during the first trimester of pregnancy. Eur J Endocrinol 2009; 160: 791-7.
13. Horacek J, Spitalnikova S, Dlabalova B, Malirova E, Vizda J, Svilias I, Cepkova J, McGrath C, Maly J. Universal screening detects two-times more thyroid disorders in early pregnancy than targeted high-risk case finding. Eur J Endo-crinol 2010; 163: 645-50.
14. Su PY, Huang K, Hao JH, Xu YQ, Yan SQ, Li T, Xu YH, Tao FB. Maternal thyroid function in the first twenty weeks of pregnancy and subsequent fetal and infant development: a prospective population-based cohort study in China. J Clin Endocrinol Metab 2011; 96: 3234-41.
15. Finken MJ, van Eijsden M, Loomans EM, Vrijkotte TG, Rotteveel J. Maternal hypothyroxinemia in early pregnancy predicts reduced performance in reaction time tests in 5-to 6-year-old offspring. J Clin Endocrinol Metab 2013; 98: 1417-26.
16. Haddow JE. Maternal thyroxine and fetal brain development: the latest chapter, a look back, and considerations for the future. J Clin Endocrinol Metab 2013; 98: 1388-90.
17. Henrichs J, Bongers-Schokking JJ, Schenk JJ, Ghassabian A, Schmidt HG, Visser TJ, Hooijkaas H, de Muinck Keizer-Schrama SM, Hofman A, Jaddoe VV, Visser W, Steegers EA, Verhulst FC, de Rijke YB, Tiermeier H. Maternal thyroid function during early pregnancy and cognitive functioning in early childhood: the generation R study. J Clin Endo-crinol Metab 2010; 95: 4227-34.
18. Thangarantinam S, Tan A, Knox E, Kilby MD, Franklyn J, Coomarsamy A. Association between thyroid autoanti-bodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ 2011; 9: 342.d2616.
19. Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5-5.0 in the first trimester of pregnancy. J Clin Endocrinol Metab 2010; 95: E44-8.
20. Stricker RT, Echenard M, Eberhart R, Chevalier MC, Perez V, Quinn FA, Stricker RN. Evaluation of maternal thyroid function during pregnancy: the importance of using gestational age-specific reference intervals. Eur J Endocrinol 2007; 157: 509-14. (Pubitemid 350018455)
21. Marwaha RK, Chopra S, Gopalakrishnan S, Sharma B, Kanvar RS, Sastry A, Singh S. Establishment of reference range for thyroid hormones in normal pregnant Indian women. BJOG, IJOG 2008; 115: 602-6. (Pubitemid 351357586)
22. Thienpont LM, Van Uytfanghe K, Beastall G, Faix JD, Ieiri T, Miller WG, Nelson JC, Ronin C, Alec Ross HA, Thijssen JH, Toussaint B. Report of the IFCC Working Group for Standardization of Thyroid Function Tests; Part 1: Thyroid-Stimulating Hormone. Clin Chem 2010; 56: 902-11.
23. Thienpont LM, Van Uytfanghe K, Beastall G, Faix JD, Ieiri T, Miller WG, Nelson JC, Ronin C, Alec Ross HA, Thijssen JH, Toussaint B. Report of the IFCC Working Group for Standardization of Thyroid Function Tests; Part 2: Free Thyroxine and Free Triiodothyronine. Clin Chem 2010; 56: 912-20.
24. Midgley JE, Christofides ND. Free thyroxine assays: no going back! Am J Obstet Gynecol 2010; 202: e6.
25. Lee RH, Spencer CA, Mestman JH, Miller EA, Petrovic I, Braverman LE, Goodwin TM. Free T4 immunoassays are flawed during pregnancy. Am J Obstet Gynecol 2009; 200: 260. e1-260.e6.
26. Zamrazil V, Bilek R, Cerovska J, Delange F. The elimination of iodine deficiency in the Czech Republic: the steps toward success. Thyroid 2004; 14: 49-56. (Pubitemid 38282937)
27. Demers LM, Spencer CA. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Clin Endocrinol 2003; 58: 138-40.
28. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87: 489-99. (Pubitemid 34158210)
29. La'ulu SL, Roberts RL. Ethnic differences in first-trimester thyroid reference intervals. Clin Chem 2011; 57: 913-26.
30. Lazarus JH. Screening for thyroid dysfunction in pregnancy: is it worthwhile? J Thyroid Res 2011; 2011: 397012. ECE 2011-08-20.
31. Hamm MP, Chery NM, Martin JW, Bamforth F, Burstyn I. The impact of isolated maternal hypothyroxinemia on perinatal morbidity. J Obstet Gynecol Can 2009; 31: 1015-21.
32. Limanova Z, Springer D. Thyropathy examination during pregnancy. Results of pilot project. Cas Lek Ces 2011; 150: 389-93.
33. Anckaert E, Poppe K, Van Uytfanghe K, Schiettecatte J, Foulon W, Thienpont LM. FT4 immunoassays may display a pattern during pregnancy similar to the equilibrium dialysis ID-LC/tandem MS candidate reference measurement procedure in spite of susceptibility towards binding protein alterations. Clin Chim A 2010; 411: 1348-53.
34. Gong Y, Hoffman BR. Free thyroxine reference interval in each trimester of pregnancy determined with the Roche Modular E-170 electrochemiluminescent immunoassay. Clin Biochem 2008; 41: 902-6.
35. Gronowski AM, Haddow J, Kilpatrick S, Lazarus JH, Negro R. Thyroid function during pregnancy: who and how should we screen? Clin Chem 2012; 58: 1397-401.
36. McLachlan SM, Rapoport B. Thyrotropin-blocking autoan-tibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypo-thyroidism to hyperthyroidism or vice versa. Thyroid 2013; 23: 14-24.
37. Yassa L, Marqusee E, Fawcett R, Alexander EK. Thyroid hormone early adjustment in pregnancy (The THERAPY) Trial. J Clin Endocrinol Metab 2010; 95: 3234-41.
38. Negro R, Formoso G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab 2006; 91: 2587-91. (Pubitemid 44024622)